Treatment for Breast Cancer
Phase-Based Progress Estimates
Effectiveness
Safety
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Breast Cancer+2 MoreEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This research study is being done to implement a screening program for prediabetes, diabetes, dyslipidemia and/or hyperlipidemia, and higher risk of cardiovascular disease in breast cancer survivors. This program will also help to direct individuals with risk factors to community and institutional resources for management.
Eligible Conditions
- Breast Cancer
- Breast
Treatment Effectiveness
Effectiveness Progress
Study Objectives
11 Primary · 19 Secondary · Reporting Duration: 3 years
3 years
Cardiovascular risk factors (family history)
Cardiovascular risk factors (hypertension)
Cardiovascular risk factors (tobacco use)
Incidence of diabetes in women with breast cancer versus healthy individuals
Incidence of hyperlipidemia in women with breast cancer versus healthy individuals
Incidence of prediabetes in women with breast cancer versus healthy individuals
Number of breast cancer patients with cardiovascular risk factors (family history)
Number of breast cancer patients with cardiovascular risk factors (hypertension)
Number of breast cancer patients with cardiovascular risk factors (obesity)
Number of breast cancer patients with cardiovascular risk factors (tobacco use)
Number of referrals for individuals with diabetes
Number of referrals for individuals with pre-diabetes
Number of referrals for individuals with risk of cardiovascular disease
Prevalence of diabetes
Prevalence of diabetes in women with breast cancer versus healthy individuals
Prevalence of hyperlipidemia
Prevalence of hyperlipidemia in women with breast cancer versus healthy individuals
Prevalence of prediabetes
Prevalence of prediabetes in women with breast cancer versus healthy individuals
Referrals for individuals with diabetes
Referrals for individuals with pre-diabetes
Referrals for individuals with risk of cardiovascular disease
Month 12
Breast-specific symptoms assessed by the of The European Organisation for Research and Treatment Cancer Quality of Life Questionnaire BR-23
Change in Body Mass Index (BMI)
Change in HbA1c
Change in LDL cholesterol
Change in Quality of Life as assessed by the Quality of Life Questionnaire C30
Change in Quality of Life as assessed by the The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire
Prevalence of obesity/ overweight
Quality of Life Questionnaire The European Organisation for Research and Treatment Cancer C30
Trial Safety
Safety Progress
Trial Design
0 Treatment Group
450 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 years
Closest Location: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Baltimore, MD
2011First Recorded Clinical Trial
42 TrialsResearching Breast Cancer
311 CompletedClinical Trials
Who is running the clinical trial?
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLead Sponsor
531 Previous Clinical Trials
30,603 Total Patients Enrolled
42 Trials studying Breast Cancer
4,455 Patients Enrolled for Breast Cancer
Jennifer Sheng, M.D.Principal InvestigatorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You must be able to speak and read English.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Top Oncology Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments